Ataraxis AI

Ataraxis AI is a small, four-employee company based in New York, United States. Ataraxis AI specializes in developing AI-powered solutions for cancer diagnostics and treatment. They focus on improving patient outcomes through the use of cutting-edge foundation models and multi-modal data analysis. Their first clinically validated product, Ataraxis Breast, is an AI-native prognostic and predictive test for breast cancer, designed to offer greater accuracy compared to traditional genomic assays. The company's key differentiator lies in its AI-native approach to cancer diagnostics. By leveraging the power of artificial intelligence, Ataraxis AI aims to address previously intractable challenges in cancer prognosis and treatment selection. For more information about Ataraxis AI and its solutions, visit their website at ataraxis.ai.